logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9260717 B1

PDFFull Text
Date of Patent:
Feb. 16, 2016

Filed:

Aug. 20, 2012

Method of screening for chaperonin modulator

Applicants:

Kyong Tai Kim, Pohang-si, KR;

Sangjune Kim, Gwangju, KR;

Inventors:

Kyong Tai Kim, Pohang-si, KR;

Sangjune Kim, Gwangju, KR;

Assignee:

POSTECH ACADEMY-INDUSTRY FOUNDATION, Pohang-Si, KR;

Attorney:

Lex IP Meister, PLLC

Primary Examiner:

Jane Zara

Int. Cl.
CPC ...
G01N 33/15 (2006.01); A61P 25/28 (2006.01); C12N 15/113 (2010.01); C12Q 1/48 (2006.01); C12Q 1/68 (2006.01); G01N 33/573 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 31/713 (2013.01); C12Q 1/485 (2013.01); C12Q 1/6809 (2013.01); G01N 33/573 (2013.01); G01N 2500/02 (2013.01); G01N 2500/04 (2013.01);
Abstract

The present invention relates to a method of screening for modulator of chaperonin that is involved in protein aggregation inducing neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease, use of the chaperonin modulator screened by the method for prevention and treatment of neurodegenerative diseases. According to the present invention, novel negative chaperonin modulator is provided, and chaperonin modulator may be more rapidly and conveniently screened with the negative modulator as a target. Furthermore, by using the screened material, neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease may be effectively prevented or treated without concern for cell death due to autophagy, which is the existing method of removing protein aggregate.

Find Patent Forward Citations

Kim, Kyong. (2016). Method of screening for chaperonin modulator (U.S. Patent No. 9260717). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9260717

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…